The purpose of this notice is to inform applicants of a change to the Key Dates for RFA-NS-18-023 "BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Required)". This Funding Opportunity Announcement has been extended by one council round. The dates have been modified to add a New Application Due Date of February 22, 2021.
Find Funding Opportunities
COVID-19 Funding Notices | Approved Initiative Concepts | Research Opportunity Announcements
All NINDS-related notices of funding opportunities (NOFOs), request for applications (RFAs), program announcements (PAs), and other NIH Guide announcements are listed. Search the Closed Opportunities tab to find expired opportunities. Search the Notices tab to find all Notices.
Learn more about award types and program directors and managers.
NINDS has a number of open positions for researchers and clinicians to contribute to exciting neuroscience programs - APPLY NOW!
For more focused results add quotes to indicate parameters. Example format: "search term".
Notice Change Key Dates PAR-18-628 NeuroNEXT Small Business Innovation Clinical Trials U44 Clinical Trial Optional)" Notice Number: NOT-NS-20-090 Key Dates Release Date: August 11, 2020 Related Announcements PAR-18-628 - NeuroNEXT Small Business Innovation Clinical Trials U44 Clinical Trial Optional) Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this notice to inform interested applicants a change the Key Dates PAR-18-628 "NeuroNEXT Small Business Innovation Clinical Trials U44 Clinical Trial Optional)(changes shown below bold italics). This Funding Opportunity Announcement been extended one additional council round. dates been modified add following New Application Due Date: April 5, 2021. Currently Reads: Part 1. Overview Information Key Dates Application Due Date(s) Standard dates apply , 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Scientific Merit Review Standard dates apply Advisory Council Review Standard dates apply Earliest Start Date Standard dates apply Expiration Date January 6, 2021 Modified Read: Part 1. Overview Information Key Dates Application Due Date(s) Standard dates apply , 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Scientific Merit Review Standard dates apply Advisory Council Review Standard dates apply Earliest Start Date Standard dates apply Expiration Date April 6, 2021 other aspects this FOA remain unchanged. Inquiries Please direct inquiries to: Codrin Lungu, MD National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-9135 Email: lunguci@ninds.nih.gov
Notice Change Key Dates PAR-18-528 NeuroNEXT Clinical Trials U01 Clinical Trial Optional)" Notice Number: NOT-NS-20-084 Key Dates Release Date: August 10, 2020 Related Announcements PAR-18-528 - NeuroNEXT Clinical Trials U01 Clinical Trial Optional) Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this notice to inform interested applicants a change the Key Dates PAR-18-528 "NeuroNEXT Clinical Trials U01 Clinical Trial Optional)" changes show below bold italics). Funding Opportunity Announcement been extended one additional council round. dates been modified add following New Application Due Date: February 5, 2021 Renewal, Resubmission, Revision Due Date: March 5, 2021. Currently Reads: Part 1. Overview Information Key Dates Application Due Date(s) Standard dates apply , 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Scientific Merit Review Standard dates apply Advisory Council Review Standard dates apply Earliest Start Date Standard dates apply Expiration Date January 8, 2021 Modified Read: Part 1. Overview Information Key Dates Application Due Date(s) Standard dates apply , 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Scientific Merit Review Standard dates apply Advisory Council Review Standard dates apply Earliest Start Date Standard dates apply Expiration Date March 6, 2021 other aspects this FOA remain unchanged. Inquiries Please direct inquiries to: Codrin Lungu, MD National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-9135 Email: lunguci@ninds.nih.gov